Skip to main content
SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · IEX Real-Time Price · USD
1.540
+0.070 (4.76%)
Apr 26, 2024, 4:00 PM EDT - Market closed

SCYNEXIS Revenue

In the year 2023, SCYNEXIS had annual revenue of $140.14M with 2,652.72% growth. Revenue in the quarter ending December 31, 2023 was $5.80M with 280.38% year-over-year growth.

Revenue (ttm)
$140.14M
Revenue Growth
+2,652.72%
P/S Ratio
0.41
Revenue / Employee
$4,832,448
Employees
29
Market Cap
58.14M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 20200--
Dec 31, 2019121.00K-136.00K-52.92%
Dec 31, 2018257.00K--
Dec 31, 2017257.00K--
Dec 31, 2016257.00K--
Dec 31, 2015257.00K-999.00K-79.54%
Dec 31, 20141.26M-15.60M-92.55%
Dec 31, 201316.86M20.00K0.12%
Dec 31, 201216.84M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cidara Therapeutics 63.91M
Theratechnologies 57.85M
Equillium 36.08M
Sensus Healthcare 24.41M
Prenetics Global 21.74M
Aligos Therapeutics 15.53M
Revenue Rankings

SCYX News

More News